BRIEF published on 03/18/2026 at 14:25, 5 months 30 days ago The Vanguard Group Discloses Position in Schroders plc Ordinary Shares Form 8.3 Takeover Code Schroders Plc Vanguard Group
BRIEF published on 03/18/2026 at 14:23, 5 months 30 days ago The Vanguard Group Discloses Position in Beazley plc Form 8.3 Takeover Code Vanguard Group Shareholding Beazley Plc
BRIEF published on 03/18/2026 at 14:22, 5 months 30 days ago Vanguard Group Discloses Stake in JTC plc Takeover Code Securities Disclosure Vanguard Group Shareholding JTC Plc
PRESS RELEASE published on 03/18/2026 at 14:20, 5 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.53% stake in Schroders plc as of 17 March 2026. Details in Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Rule 8.3 Takeover Code Schroders Plc Vanguard Group
PRESS RELEASE published on 03/18/2026 at 14:18, 5 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.04% stake in Beazley plc as of 17 March 2026. Purchase of 8,740 5p ordinary shares at 12.90 GBP per unit revealed The Vanguard Group Stake Disclosure Purchase Disclosure 5.04% Beazley Plc
PRESS RELEASE published on 03/18/2026 at 14:17, 5 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.09% interest in JTC plc with 8,778,002 securities owned. Detailed Form 8.3 filing per Takeover Code Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
BRIEF published on 03/17/2026 at 15:24, 6 months ago The Vanguard Group Reports Position in Spire Healthcare Ordinary Shares The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare
BRIEF published on 03/17/2026 at 15:22, 6 months ago The Vanguard Group Publishes Disclosure on Schroders PLC Form 8.3 Takeover Code Securities Disclosure Schroders Plc Vanguard Group
BRIEF published on 03/17/2026 at 15:21, 6 months ago The Vanguard Group, Inc. Discloses Position in Picton Property Income Ltd Form 8.3 Takeover Code Securities Disclosure Vanguard Group Picton Property Income
BRIEF published on 03/17/2026 at 15:19, 6 months ago The Vanguard Group, Inc. Discloses Stake in NCC Group PLC Disclosure Takeover Code Vanguard Group Shareholding NCC Group Plc
Published on 09/17/2026 at 15:55, 2 hours 11 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 2 hours 41 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 3 hours 6 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 3 hours 6 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 3 hours 16 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 17:46, 19 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:45, 20 minutes ago Huawei Pioneers a New Computing Architecture for the AI Era: Making One Million Processors Work as One Computer
Published on 09/17/2026 at 17:45, 20 minutes ago Press release: Information on Leonteq's shareholder base
Published on 09/17/2026 at 17:30, 35 minutes ago AML RightSource Recognized with CobraSight Award for Digital Asset Compliance Expertise
Published on 09/17/2026 at 17:15, 50 minutes ago Huawei Unveils the Industry's First NPO Optical Engine with Built-in Light Source, Hi-ONE, Leading the Way in High-Speed Optical Interconnect Technology Innovation
Published on 09/17/2026 at 17:40, 26 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 07:00, 1 day 11 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
